CSF Aβ(42) and tau in Parkinson’s disease with cognitive impairment

We tested the hypothesis that the CSF biomarker signature associated with Alzheimer’s disease (AD) is present in a subset of individuals with Parkinson’s disease and Dementia (PD-D) or with PD and Cognitive Impairment, Not Dementia (PD-CIND). We quantified CSF Aβ(42), total tau (T-tau), and phospho-...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Montine, Thomas J., Shi, Min, Quinn, Joseph F., Peskind, Elaine R., Craft, Suzanne, Ginghina, Carmen, Chung, Kathryn A., Kim, Hojoong, Galasko, Douglas R., Jankovic, Joseph, Zabetian, Cyrus P., Leverenz, James B., Zhang, Jing
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2978754/
https://ncbi.nlm.nih.gov/pubmed/20818673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.23287
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares